Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A critical period for social experience-dependent oligodendrocyte maturation and myelination.
Levels of mRNA for dopaminergic receptor D5 in circulating lymphocytes may be associated with subsequent response to interferon-β in patients with multiple sclerosis.
Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines?
The active form of vitamin D transcriptionally represses the Smad7 signaling and activates ERK to inhibit the differentiation of a inflammatory T helper cell subset and suppress experimental autoimmune encephalomyelitis.
Mature oligodendrocytes actively increase in vivo cytoskeletal plasticity following CNS damage.
Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.
Effects of Brain-Derived IL-2 Deficiency and the Development of Autoimmunity on Spatial Learning and Fear Conditioning.
Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord While Preserving Peripheral Regulatory Mechanisms.
2-Cyclopropylimino-3-Methyl-1,3-Thiazoline Hydrochloride Inhibits Microglial Activation by Suppression of Nuclear Factor-Kappa B and Mitogen-Activated Protein Kinase Signaling.
Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function.
Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation.
Pain in experimental autoimmune encephalitis: a comparative study between different mouse models.
Neurogenic detrusor overactivity: an update on management options.
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
Expression of Lymphatic Markers in the Adult Rat Spinal Cord.
A Further TWEAK to Multiple Sclerosis Pathophysiology.
Combined therapy with methylprednisolone and ulinastatin in experimental autoimmune encephalomyelitis.
Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice.
Mood and coping in clinically isolated syndrome and multiple sclerosis.
Intrathecal immune reset in multiple sclerosis: Exploring a new concept.
KCHO-1, a Novel Antineuroinflammatory Agent, Inhibits Lipopolysaccharide-Induced Neuroinflammatory Responses through Nrf2-Mediated Heme Oxygenase-1 Expression in Mouse BV2 Microglia Cells.
Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
Multiple sclerosis: Cannabis use is associated with deleterious brain changes in patients with multiple sclerosis.
Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study.

Pages